Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation in gynecological day surgery
ChiCTR2200056240Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guilin Medical University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in gynaecological conditions (2 arms), sponsored by The First Affiliated Hospital of Guilin Medical University. Primary endpoints: Bispectral Index (BIS) value, Total amount of medication and 1 more. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2200056240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056240.